JPRN-UMIN000030124已完成未知
A phase II study about the efficacy of an intervention of excercise therapy on the adjuvant chemotherapy for pancreatic cancer: Exercise-PC Study - Exercise impact on adjuvant chemotherapy for pancreatic cancer
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 43
研究概览
简要总结
The completion rate of S-1 therapy, which is the primary endpoint, was 93% , which exceeded the threshold completion rate of 53% (P < 0.001).
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Severe drug hypersensitivity or drug allergy 2. Multiple primary cancers within 5 years. 3. Severe infection 4. With watery diarrhea 5. Interstitial pneumonia or pulmonary fibrosis 6. With uncontrollable pleural effusion or ascites 7. With uncontrollable diabetes mellitus 8. With severe heart failure, angina, hypertension, arrhythmia 9. Walking akinesia 10. With severe malnutrition 11. With severe neurological/psychological symptoms 12. Pregnant or lactating women or women with unknown or suspected pregnancy
研究者
相似试验
已完成
2 期
A phase II study to confirm the effectiveness of a element supplement "Elental" for patients who are administered TS-1 after surgical resection (OGSG 1108)Gastric CancerJPRN-UMIN000006872Osaka Gastrointestinal cancer chemotherapy Study Group (OGSG)82
已完成
不适用
n-blinded Multicenter Study to Assess the Safety and Efficacy of Robotic-assisted (da Vinci surgical system, DVSS) Laparoscopic Partial Nephrectomy for Renal Cell Carcinoma PatientscT1 Renal CanserJPRN-UMIN000013964Kobe University Graduate School of Medicine118
已完成
2 期
A phase II study of palliative treatment with metallic stents for inoperable malignant colorectal strictures. (JIVROSG-0206)Inoperable malignant colorectal strictures.JPRN-C000000044Japan Interventional Radiology in Oncology Study Group (JIVROSG)33
已完成
不适用
A phase II study of S-1 therapy for advanced/recurrent esophageal cancer resistant/intolerable to 5-FU, Platinum compounds, and Taxane (OGSG1404)Esophageal carcinomaJPRN-UMIN000016830Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)17
已完成
2 期
A randomized phase II study of daily administrations versus alternate-day administrations of TS-1 for the elderly patient with completely resected pathological stage IA(T1bN0M0)-IIIA of non-small cell lung canceron Small Cell Lung CancerJPRN-UMIN000007819Setouchi Lung Cancer Group101